SKYSTAR BIO-PHARMACEUTICAL CO Financing Cash Flow
SKYSTAR BIO-PHARMACEUTICAL CO reported Financing Cash Flow of $5.60 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2013-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) financing activities for the quarter ending 2013-09-30 was $644.70K, a 82.56% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) financing activities for the quarter ending 2013-06-30 was $2.36M.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) financing activities for the quarter ending 2013-03-31 was $2.59M, a 565.11% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) financing activities for the quarter ending 2012-12-31 was -$4.15M, a 207.98% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) financing activities for fiscal 2012 was -$779.28K, a 119.07% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) financing activities for fiscal 2011 was $4.09M, a 54.20% increase from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) financing activities for fiscal 2010 was $2.65M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2013-09-30 | $644.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $3.01M derived: sum of 2 quarters · filed 2013-11-14 | $5.60M 10-Q · filed 2013-11-14 | $1.44M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2013-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $4.95M 10-Q · filed 2013-08-14 | $797.42K derived: sum of 3 quarters · filed 2013-08-14 | $4.49M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2013-03-31 | $2.59M 10-Q · filed 2013-05-15 | -$1.56M derived: sum of 2 quarters · filed 2013-05-15 | $2.13M derived: sum of 3 quarters · filed 2013-11-14 | $1.42M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2012-12-31 | -$4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$457.28K derived: sum of 2 quarters · filed 2013-11-14 | -$1.17M derived: sum of 3 quarters · filed 2013-11-14 | -$779.28K 10-K · filed 2013-04-01 | ||
| 2012-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $2.99M derived: sum of 2 quarters · filed 2013-11-14 | $3.37M 10-Q · filed 2013-11-14 | $3.06M 10-Q · filed 2012-11-14 | $7.22M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | -$711.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$322.01K 10-Q · filed 2013-08-14 | -$639.33K 10-Q/A · filed 2012-09-13 | $3.53M derived: sum of 3 quarters · filed 2013-08-14 | $2.46M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $389.58K 10-Q · filed 2013-05-15 | $4.24M derived: sum of 2 quarters · filed 2013-05-15 | $3.17M derived: sum of 3 quarters · filed 2013-05-15 | $3.16M derived: sum of 4 quarters · filed 2013-05-15 | ||
| 2011-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $2.78M derived: sum of 2 quarters · filed 2013-04-01 | $2.77M derived: sum of 3 quarters · filed 2013-04-01 | $4.09M 10-K · filed 2013-04-01 | ||
| 2011-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$1.08M derived: sum of 2 quarters · filed 2012-11-14 | $238.64K 10-Q · filed 2012-11-14 | $1.56M derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-06-30 | -$17.63K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | $1.30M 10-Q/A · filed 2012-09-13 | $2.63M derived: sum of 3 quarters · filed 2012-09-13 | $4.33M derived: sum of 4 quarters · filed 2012-09-13 | ||
| 2011-03-31 | $1.32M 10-Q · filed 2012-05-15 | $2.65M derived: sum of 2 quarters · filed 2012-05-15 | $4.35M derived: sum of 3 quarters · filed 2012-05-15 | |||
| 2010-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $3.03M derived: sum of 2 quarters · filed 2012-03-30 | $2.65M 10-K · filed 2012-03-30 | |||
| 2010-09-30 | $1.70M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $1.32M 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | -$377.93K 10-Q/A · filed 2011-09-21 |